After a successful career in entrepreneurship and cryptocurrency, Ryan Zurrer turned his attention to the burgeoning psychedelic space. As he continued to learn more via research, attending conferences, and speaking with others, he became concerned about what he considers the "dystopian future" of psychedelic therapies - sterile doctors' offices, $8000 treatments, synthetic drugs, no community or connection. Determined to help others harness the powerful benefits of plant medicines in traditional settings, he started Vine Ventures, a VC fund focusing on a future in which everyone who wants to access a psychedelic experience can do so safely, legally, and affordably. In this episode, Ryan and Paul discuss the importance of accessibility, Ryan's criteria for investment, and the differences between a centralized and decentralized approach to therapy and legalization.